ToxicoGenomica recently presented at the National Asbestos Litigation Conference (September 12-13, 2023) hosted by Perrin Conferences and the slides are now available for download. Len van Zyl, Ph.D, and CEO of ArrayXpress participated in an engaging panel moderated by Douglas Sinars, Esq. and titled Medical & Scientific Literature Update on Asbestos & Mesothelioma. The panel […]
ToxicoGenomica recently presented a webinar organized by Perrin Conferences and the slides are now available for download. The webinar focused on the latest publications, scientific studies, and statistics regarding genomics role in cancers. It also covered predictive software and other tools for understanding the impact of germline mutations on disease development and progression. The speakers […]
Join us for this complimentary CLE webinar on Tuesday, July 18, 2023 from 2:00-3:30 pm ET. This webinar will focus on the latest publications, scientific studies, and statistics regarding genomics role in cancers. It will also cover predictive software and other tools for understanding the impact of germline mutations on disease development and progression. There […]
Kirk Hartley of ToxicoGenomica will cover the topic of the continually increasing value of genomic analysis to evaluate mesothelioma causation at the upcoming Perrin Conference on Cutting-Edge Issues in Asbestos Litigation. As part of a panel on genetics and science, Kirk will discuss important new papers with data showing the increasing findings of genomic drivers of mesotheliomas. One portion […]
ToxicoGenomica recently presented a webinar organized by Perrin Conferences and the slides are now available for download. The title of the session was Key Developments: Genomics in Mesothelioma Cases. The webinar focused on the latest cases, the most recent science and publications, and the evolving applications and cost of deployment of the science of genomics […]
Complimentary CLE Webinar Thursday, December 1st, 2022 1:30-2:45 ET Click Here For More Information and to Register This webinar will focus on the latest cases, the most recent science and publications, and the evolving applications and cost of deployment of the science of genomics to understanding the causes of cancer. MEET THE SPEAKERS • Kirk […]
At our recent conference Genomic Analysis in Tort Cases, the last panel of the conference focused on uses for genomics in “high value” settings, including a further focus on uses in cancer cluster cases and medical monitoring cases. Panelists discussed by genomics may represent the best defense in a cancer cluster case, and Kirk Hartley provided a […]
At our recent conference Genomic Analysis in Tort Cases, one of the panels focused primarily on communicating genomic issues to juries and judges, including extensive slides and comments from Magna Legal on communicating the concepts of genetic predisposition and “susceptibility” to cancer, where the defense often seeks to make genetic predisposition arguments and plaintiffs often […]
At our recent conference Genomic Analysis in Tort Cases, panelists presented examples of results in “environmental cases” in which genomic analyses was used to provide objective evidence to trace sources of exposure and dispersal, and uses of genomic analyses for cancer cluster cases. The panel provided the perspective that genomics are well-suited to the injuries […]
At our recent conference Genomic Analysis in Tort Cases, Michael Zapata III and Leonel van Zyl, PhD provided an in depth review and analysis of the nuts and bolts for using genomic analysis in legal cases. Michael and Dr. van Zyl explained their systematic and gated methodology for helping clients considering whether a genomic approach […]